264 related articles for article (PubMed ID: 27217767)
1. Irreversible electroporation: state of the art.
Wagstaff PG; Buijs M; van den Bos W; de Bruin DM; Zondervan PJ; de la Rosette JJ; Laguna Pes MP
Onco Targets Ther; 2016; 9():2437-46. PubMed ID: 27217767
[TBL] [Abstract][Full Text] [Related]
2. New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors.
Yun JH; Fang A; Khorshidi F; Habibollahi P; Kutsenko O; Etezadi V; Hunt S; Nezami N
Curr Oncol Rep; 2023 Nov; 25(11):1213-1226. PubMed ID: 37695398
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model.
Dunki-Jacobs EM; Philips P; Martin RC
Br J Surg; 2014 Aug; 101(9):1113-21. PubMed ID: 24961953
[TBL] [Abstract][Full Text] [Related]
4. Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy.
Davalos RV; Bhonsle S; Neal RE
Prostate; 2015 Jul; 75(10):1114-8. PubMed ID: 25809014
[TBL] [Abstract][Full Text] [Related]
5. Irreversible Electroporation in Interventional Oncology: Where We Stand and Where We Go.
Savic LJ; Chapiro J; Hamm B; Gebauer B; Collettini F
Rofo; 2016 Aug; 188(8):735-45. PubMed ID: 27074423
[TBL] [Abstract][Full Text] [Related]
6. Thermodynamic profiling during irreversible electroporation in porcine liver and pancreas: a case study series.
Agnass P; van Veldhuisen E; Vogel JA; Kok HP; de Keijzer MJ; Schooneveldt G; de Haan LR; Klaessens JH; Scheffer HJ; Meijerink MR; van Lienden KP; van Gulik TM; Heger M; Crezee J; Besselink MG
J Clin Transl Res; 2020 Apr; 5(3):109-132. PubMed ID: 32617426
[TBL] [Abstract][Full Text] [Related]
7. The Enlargement of Ablation Area by Electrolytic Irreversible Electroporation (E-IRE) Using Pulsed Field with Bias DC Field.
Lv Y; Liu H; Feng Z; Zhang J; Chen G; Yao C
Ann Biomed Eng; 2022 Dec; 50(12):1964-1973. PubMed ID: 35852648
[TBL] [Abstract][Full Text] [Related]
8. Irreversible electroporation: implications for prostate ablation.
Onik G; Mikus P; Rubinsky B
Technol Cancer Res Treat; 2007 Aug; 6(4):295-300. PubMed ID: 17668936
[TBL] [Abstract][Full Text] [Related]
9. Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial.
Scheltema MJ; van den Bos W; de Bruin DM; Wijkstra H; Laguna MP; de Reijke TM; de la Rosette JJ
BMC Cancer; 2016 May; 16():299. PubMed ID: 27150293
[TBL] [Abstract][Full Text] [Related]
10. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
[TBL] [Abstract][Full Text] [Related]
11. Irreversible electroporation of the pancreas: definitive local therapy without systemic effects.
Bower M; Sherwood L; Li Y; Martin R
J Surg Oncol; 2011 Jul; 104(1):22-8. PubMed ID: 21360714
[TBL] [Abstract][Full Text] [Related]
12. An overview of the irreversible electroporation for the treatment of liver metastases: When to use it.
Belfiore MP; De Chiara M; Reginelli A; Clemente A; Urraro F; Grassi R; Belfiore G; Cappabianca S
Front Oncol; 2022; 12():943176. PubMed ID: 36119531
[TBL] [Abstract][Full Text] [Related]
13. A Comprehensive Characterization of Parameters Affecting High-Frequency Irreversible Electroporation Lesions.
Miklovic T; Latouche EL; DeWitt MR; Davalos RV; Sano MB
Ann Biomed Eng; 2017 Nov; 45(11):2524-2534. PubMed ID: 28721494
[TBL] [Abstract][Full Text] [Related]
14. Irreversible Electroporation for the Ablation of Prostate Cancer.
Karagiannis A; Varkarakis J
Curr Urol Rep; 2019 Sep; 20(10):63. PubMed ID: 31478109
[TBL] [Abstract][Full Text] [Related]
15. Irreversible Electroporation of the Hepatobiliary System: Current Utilization and Future Avenues.
Narayanan G; Koethe Y; Gentile N
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399539
[TBL] [Abstract][Full Text] [Related]
16. Irreversible electroporation: Beyond the limits of tumor ablation.
Alonso-González R; Abadal Villayandre JM; Gálvez Gonzalez E; Álvarez Perez MJ; Méndez Alonso S; de Gregorio Ariza MA
Radiologia (Engl Ed); 2024; 66(1):47-56. PubMed ID: 38365354
[TBL] [Abstract][Full Text] [Related]
17. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
[TBL] [Abstract][Full Text] [Related]
18. High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction.
Arena CB; Sano MB; Rossmeisl JH; Caldwell JL; Garcia PA; Rylander MN; Davalos RV
Biomed Eng Online; 2011 Nov; 10():102. PubMed ID: 22104372
[TBL] [Abstract][Full Text] [Related]
19. The Induction of Combined Hyperthermal Ablation Effect of Irreversible Electroporation with Polydopamine Nanoparticle-Coated Electrodes.
Jeon SM; Davaa E; Jenjob R; Pechyen C; Natphopsuk S; Jeong S; Yoo HJ; Yang SG
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673901
[TBL] [Abstract][Full Text] [Related]
20. Irreversible Electroporation: An Emerging Immunomodulatory Therapy on Solid Tumors.
Zhang N; Li Z; Han X; Zhu Z; Li Z; Zhao Y; Liu Z; Lv Y
Front Immunol; 2021; 12():811726. PubMed ID: 35069599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
